Replay available

Syndax Pharmaceuticals, Inc. (SNDX) Q1 2025 Earnings Call

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) Q1 2025 earnings conference call, held 2025-05-05. Replay captured from the company's public earnings webcast.

Mon, May 5, 2025 at 4:30 PMendedReplay
Syndax Pharmaceuticals, Inc. (SNDX) Q1 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Sharon Clary

Head of Investor Relations

Michael Metzger

Chief Executive Officer

Steve Kloster

Chief Commercial Officer

Neil Gallagher

President & Head of R&D

Keith Goldan

Chief Financial Officer

Replay transcript excerpt

Testing one, two, testing one, two. I know it takes a while to get there. So testing one, two. All righty, all righty. Check one, two. Awesome. Thanks, Micah. There we go. Let's see. There we go. Zoom. Zoom audio coming through in the preview. Confirm mod working okay for you, Nicole? I see you're in and out a few times, like you're trying to get it to work or something. Yeah, it's so dramatic when it does that. But no, it's just that I didn't know that when it comes in as a certain type of user, it doesn't let you edit them, like each one of what me and Angela were talking about. Oh, wow. Yeah, so that's why I couldn't keep the last name and company. It only gives me the option to just change where it says first name. Does that make sense? Right, yeah. Cool. Yeah. So, for example, like Elijah, James, and primary backup, it shows the option to edit the user. But for everyone else, like me in the Zoom room, that's a link user. Yeah, same for me. And it only gives me like a little bit. Yeah, that gives me issues too. Cool. Micah, let's switch to backup and see if we can hear participants. stream hold music. Thanks, Micah. Okay. Check, check, one, two. There I am. Awesome. And we can go back to the hold music. Excellent. That long delay really messes with me. Thank you. Let's pray. so so Thank you. Thank you. you Thank you. Thank you for watching. Thank you. Thank you. so so you Thank you. Thank you. do do Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. so so you Thank you. you Thank you. Thank you. so so Thank you for watching. so so you Thank you. Thank you. do do Thank you. Good day, everyone, and welcome to the Syndax first quarter 2025 earnings conference call. Today's ca...

More from Syndax Pharmaceuticals, Inc.